CYTOKINETICS, INCORPORATED (CYTK)

SEC filing

CYTOKINETICS, INCORPORATED

CYTK · CIK 1061983

4 · Nov 18, 2025 · Malik Fady Ibraham sold 2,200 shares at $66.45/share ($146.2K); exercised options for 2,200 shares

Malik Fady Ibraham sold 2,200 shares at $66.45/share ($146.2K); exercised options for 2,200 shares

PRIMARY DOCUMENT

xslF345X05/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).